Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Allergen or component thereof
Patent
1996-05-14
1998-06-09
Hutzell, Paula K.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Allergen or component thereof
4242751, 4242831, 4242821, 4242341, 4242571, 4241971, 424422, 424418, 424182, 424177, 424195, 424400, 424450, 424 7013, 514 54, 514960, 514 2, 530329, 536 5, 536124, A61K 3935, A61K 4500, A61K 3902
Patent
active
057629439
ABSTRACT:
Methods and compositions for treating type I immunoglobin E (IgE)-dependent hypersensitivity by the administration of monophosphoryl lipid A (MLA) or 3-deacylated monophosphoryl lipid A (3D-MLA) are disclosed. MLA or 3D-MLA administered alone or in combination with an allergen to a patient suffering from type I hypersensitivity reduces levels of total or allergen specific IgE and increases levels of IgG antibody in that patient. MLA and 3D-MLA can be administered as part of a desensitization regimen or as a component of a prophylactic vaccine to prevent a type I hypersensitivity reaction.
REFERENCES:
patent: 4432969 (1984-02-01), Batchelor
patent: 4436727 (1984-03-01), Ribi
patent: 4844894 (1989-07-01), Ribi
patent: 4912094 (1990-03-01), Myers et al.
patent: 4990336 (1991-02-01), Silvestri et al.
patent: 5013555 (1991-05-01), Collins
patent: 5073628 (1991-12-01), Matsuhashi et al.
patent: 5244663 (1993-09-01), Bruttmann et al.
Dolovich Jerry
Marshall Jean S.
Ulrich J. Terry
Hutzell Paula K.
Kullick Ronald H.
Masood Khalid
Ribi ImmunoChem Research Inc.
LandOfFree
Methods of treating type I hypersensitivity using monophosphoryl does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of treating type I hypersensitivity using monophosphoryl, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of treating type I hypersensitivity using monophosphoryl will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2195968